Literature DB >> 8409824

DRL interresponse-time distributions: quantification by peak deviation analysis.

J B Richards1, K E Sabol, L S Seiden.   

Abstract

Peak deviation analysis is a quantitative technique for characterizing interresponse-time distributions that result from training on differential-reinforcement-of-low-rate schedules of reinforcement. It compares each rat's obtained interresponse-time distribution to the corresponding negative exponential distribution that would have occurred if the rat had emitted the same number of responses randomly in time, at the same rate. The comparison of the obtained distributions with corresponding negative exponential distributions provides the basis for computing three standardized metrics (burst ratio, peak location, and peak area) that quantitatively characterize the profile of the obtained interresponse-time distributions. In Experiment 1 peak deviation analysis quantitatively described the difference between the interresponse-time distributions of rats trained on variable-interval 300-s and differential-reinforcement-of-low-rate 72-s schedules of reinforcement. In Experiment 2 peak deviation analysis differentiated between the effects of the psychomotor stimulant d-amphetamine, the anxiolytic compound chlordiazepoxide, and the antidepressant desipramine. The results suggest that peak deviation analysis of interresponse-time distributions may provide a useful behavioral assay system for characterizing the effects of drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409824      PMCID: PMC1322182          DOI: 10.1901/jeab.1993.60-361

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.468


  31 in total

1.  FREQUENCY DISTRIBUTION OF INTERRESPONSE TIMES DURING VI AND VR REINFORCEMENT.

Authors:  W KINTSCH
Journal:  J Exp Anal Behav       Date:  1965-09       Impact factor: 2.468

2.  Spaced responding in multiple DRL schedules.

Authors:  J ZIMMERMAN; C R SCHUSTER
Journal:  J Exp Anal Behav       Date:  1962-10       Impact factor: 2.468

3.  Fundamental dimensional properties of the operant.

Authors:  T F GILBERT
Journal:  Psychol Rev       Date:  1958-09       Impact factor: 8.934

4.  Technique for assessing the effects of drugs on timing behavior.

Authors:  M SIDMAN
Journal:  Science       Date:  1955-11-11       Impact factor: 47.728

5.  The dependence of interresponse times upon the relative reinforcement of different interresponse times.

Authors:  D ANGER
Journal:  J Exp Psychol       Date:  1956-09

6.  Feedback functions for variable-interval reinforcement.

Authors:  J A Nevin; W M Baum
Journal:  J Exp Anal Behav       Date:  1980-09       Impact factor: 2.468

7.  Theoretical Relationships Among Some Measures of Conditioning.

Authors:  C G Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  1950-02       Impact factor: 11.205

8.  The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats.

Authors:  P S McGuire; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

9.  The reinforcement of least-frequent interresponse times.

Authors:  D S Blough
Journal:  J Exp Anal Behav       Date:  1966-09       Impact factor: 2.468

10.  Methamphetamine and time estimation.

Authors:  A V Maricq; S Roberts; R M Church
Journal:  J Exp Psychol Anim Behav Process       Date:  1981-01
View more
  29 in total

1.  Neurotoxicity of methamphetamine and methylenedioxymethamphetamine.

Authors:  L S Seiden; R Lew; J E Malberg
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

2.  The effect of changes in criterion value on differential reinforcement of low rate schedule performance.

Authors:  Matthew J Pizzo; Kimberly Kirkpatrick; Pamela J Blundell
Journal:  J Exp Anal Behav       Date:  2009-09       Impact factor: 2.468

3.  Estradiol impairs response inhibition in young and middle-aged, but not old rats.

Authors:  Victor C Wang; Steven L Neese; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2011-01-28       Impact factor: 3.763

4.  Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats.

Authors:  Noelle C Anastasio; Erin C Stoffel; Robert G Fox; Marcy J Bubar; Kenner C Rice; Frederick G Moeller; Kathryn A Cunningham
Journal:  Behav Pharmacol       Date:  2011-06       Impact factor: 2.293

5.  Validation of a method to assess ADHD-related impulsivity in animal models.

Authors:  Elizabeth Watterson; Gabriel J Mazur; Federico Sanabria
Journal:  J Neurosci Methods       Date:  2015-04-01       Impact factor: 2.390

6.  Revisiting the effect of nicotine on interval timing.

Authors:  Carter W Daniels; Elizabeth Watterson; Raul Garcia; Gabriel J Mazur; Ryan J Brackney; Federico Sanabria
Journal:  Behav Brain Res       Date:  2015-01-29       Impact factor: 3.332

7.  Effects of multiple daily genistein treatments on delayed alternation and a differential reinforcement of low rates of responding task in middle-aged rats.

Authors:  Steven L Neese; Suren B Bandara; Daniel R Doerge; William G Helferich; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2011-09-14       Impact factor: 3.763

8.  Timing and space usage are disrupted by amphetamine in rats maintained on DRL 24-s and DRL 72-s schedules of reinforcement.

Authors:  Stephen C Fowler; Jonathan Pinkston; Elena Vorontsova
Journal:  Psychopharmacology (Berl)       Date:  2009-01-14       Impact factor: 4.530

9.  Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.

Authors:  S S Somkuwar; K M Kantak; M T Bardo; L P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2015-12-02       Impact factor: 3.533

10.  Effects of reinforcer magnitude on responding under differential-reinforcement-of-low-rate schedules of rats and pigeons.

Authors:  Adam H Doughty; Jerry B Richards
Journal:  J Exp Anal Behav       Date:  2002-07       Impact factor: 2.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.